267 related articles for article (PubMed ID: 34089171)
1. Efficacy of testosterone replacement therapy for treating metabolic disturbances in late-onset hypogonadism: a systematic review and meta-analysis.
Kim SH; Park JJ; Kim KH; Yang HJ; Kim DS; Lee CH; Jeon YS; Shim SR; Kim JH
Int Urol Nephrol; 2021 Sep; 53(9):1733-1746. PubMed ID: 34089171
[TBL] [Abstract][Full Text] [Related]
2. Systematic Review of the Impact of Testosterone Replacement Therapy on Depression in Patients with Late-onset Testosterone Deficiency.
Vartolomei MD; Kimura S; Vartolomei L; Shariat SF
Eur Urol Focus; 2020 Jan; 6(1):170-177. PubMed ID: 30017901
[TBL] [Abstract][Full Text] [Related]
3. [Testosterone replacement therapy improves metabolic indexes of the patients with hypogonadism: A meta-analysis].
Wang W; Wu J; Fan YF; Yang ZP; Zhu W; Yang GT; He JB
Zhonghua Nan Ke Xue; 2022 Oct; 28(10):926-934. PubMed ID: 37838960
[TBL] [Abstract][Full Text] [Related]
4. Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.
Cai X; Tian Y; Wu T; Cao CX; Li H; Wang KJ
Asian J Androl; 2014; 16(1):146-52. PubMed ID: 24369149
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Effects of Testosterone Replacement Therapy in Patients with Type 2 Diabetes Mellitus or Metabolic Syndrome: A Meta-Analysis.
Li SY; Zhao YL; Yang YF; Wang X; Nie M; Wu XY; Mao JF
Int J Endocrinol; 2020; 2020():4732021. PubMed ID: 33061966
[TBL] [Abstract][Full Text] [Related]
6. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis.
Kohn TP; Mata DA; Ramasamy R; Lipshultz LI
Eur Urol; 2016 Jun; 69(6):1083-90. PubMed ID: 26874809
[TBL] [Abstract][Full Text] [Related]
7. Testosterone and metabolic syndrome: a meta-analysis study.
Corona G; Monami M; Rastrelli G; Aversa A; Tishova Y; Saad F; Lenzi A; Forti G; Mannucci E; Maggi M
J Sex Med; 2011 Jan; 8(1):272-83. PubMed ID: 20807333
[TBL] [Abstract][Full Text] [Related]
8. Improved Lower Urinary Tract Symptoms Associated With Testosterone Replacement Therapy in Japanese Men With Late-Onset Hypogonadism.
Okada K; Miyake H; Ishida T; Sumii K; Enatsu N; Chiba K; Matsushita K; Fujisawa M
Am J Mens Health; 2018 Sep; 12(5):1403-1408. PubMed ID: 27256990
[TBL] [Abstract][Full Text] [Related]
9. An updated systematic review and meta-analysis of the effects of testosterone replacement therapy on erectile function and prostate.
Xu Z; Chen X; Zhou H; Ren C; Wang Q; Pan Y; Liu L; Liu X
Front Endocrinol (Lausanne); 2024; 15():1335146. PubMed ID: 38344665
[TBL] [Abstract][Full Text] [Related]
10. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients.
Wu XY; Mao JF; Lu SY; Zhang Q; Shi YF
Chin Med J (Engl); 2009 Dec; 122(23):2846-50. PubMed ID: 20092788
[TBL] [Abstract][Full Text] [Related]
11. Testosterone Replacement Therapy and Components of the Metabolic Syndrome.
Anaissie J; Roberts NH; Wang P; Yafi FA
Sex Med Rev; 2017 Apr; 5(2):200-210. PubMed ID: 28202344
[TBL] [Abstract][Full Text] [Related]
12. The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis.
Cui Y; Zong H; Yan H; Zhang Y
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):132-43. PubMed ID: 24445948
[TBL] [Abstract][Full Text] [Related]
13. Effects of testosterone replacement therapy on metabolic syndrome among Japanese hypogonadal men: A subanalysis of a prospective randomised controlled trial (EARTH study).
Shigehara K; Konaka H; Nohara T; Izumi K; Kitagawa Y; Kadono Y; Iwamoto T; Koh E; Mizokami A; Namiki M
Andrologia; 2018 Feb; 50(1):. PubMed ID: 28497534
[TBL] [Abstract][Full Text] [Related]
14. Testosterone Therapy: What We Have Learned From Trials.
Corona G; Torres LO; Maggi M
J Sex Med; 2020 Mar; 17(3):447-460. PubMed ID: 31928918
[TBL] [Abstract][Full Text] [Related]
15. Testosterone treatment in male patients with Klinefelter syndrome: a systematic review and meta-analysis.
Pizzocaro A; Vena W; Condorelli R; Radicioni A; Rastrelli G; Pasquali D; Selice R; Ferlin A; Foresta C; Jannini EA; Maggi M; Lenzi A; Pivonello R; Isidori AM; Garolla A; Francavilla S; Corona G;
J Endocrinol Invest; 2020 Dec; 43(12):1675-1687. PubMed ID: 32567016
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction, insulin resistance and inflammation in congenital hypogonadism, and the effect of testosterone replacement.
Sonmez A; Haymana C; Aydogdu A; Tapan S; Basaran Y; Meric C; Baskoy K; Dinc M; Yazici M; Taslipinar A; Barcin C; Yilmaz MI; Bolu E; Azal O
Endocr J; 2015; 62(7):605-13. PubMed ID: 25924666
[TBL] [Abstract][Full Text] [Related]
17. Oral testosterone therapy: past, present, and future.
Miller JA; Nguyen TT; Loeb C; Khera M; Yafi FA
Sex Med Rev; 2023 Apr; 11(2):124-138. PubMed ID: 36779549
[TBL] [Abstract][Full Text] [Related]
18. Influence of androgen receptor CAG polymorphism on sexual function recovery after testosterone therapy in late-onset hypogonadism.
Tirabassi G; Corona G; Biagioli A; Buldreghini E; delli Muti N; Maggi M; Balercia G
J Sex Med; 2015 Feb; 12(2):381-8. PubMed ID: 25443437
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of testosterone replacement in men with obesity: a systematic review and meta-analysis.
Mangolim AS; Brito LAR; Nunes-Nogueira VDS
Eur J Endocrinol; 2021 Dec; 186(1):123-135. PubMed ID: 34738915
[TBL] [Abstract][Full Text] [Related]
20. Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial.
Khripun I; Vorobyev S; Belousov I; Kogan M; Zitzmann M
Aging Male; 2019 Dec; 22(4):241-249. PubMed ID: 30235049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
